Taro Pharmaceuticals U.S.A., Inc. has recalled 96 tubes of Clobetasol Propionate Ointment USP, 0.05% in 60g tubes because the product may be contaminated with R. Pickettii bacteria. This bacterial contamination was discovered during routine testing of the product. No incidents or injuries related to this recall have been reported to date. This prescription ointment was distributed to wholesalers in Louisiana and Utah and may have been further distributed to retail pharmacies nationwide.
The presence of R. Pickettii bacteria in a topical ointment can cause serious skin or systemic infections, especially in individuals with weakened immune systems or preexisting skin conditions.
You have 2 options:
Manufactured by Taro Pharmaceutical Industries Ltd. in Haifa Bay, Israel.
Label, Taro Clobetasol Propionate
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.